Biogen CEO: 'Major Bottleneck' Still Limits Alzheimer's Drug - News Tags

Latest

Thursday, October 21, 2021

Biogen CEO: 'Major Bottleneck' Still Limits Alzheimer's Drug

A new Alzheimer’s drug from Biogen brought in only $300,000 in sales during its first full quarter on the market.

No comments:

Popular Posts

https://draft.blogger.com/u/1/blog/themes/edit/7199067120201458512